Newsroom
Articles
Glossary
SignalPoint
Signal On-Call
Home
Subscribe to the Trendletter
E-mail 
Search 

Bookmark and Share


      About Us            Services            Clients            Contact Us            òáøéú      
News



  Biotech co NiCast wins EU funding

The firm will head a group of ten companies and research institutes that will develop a spinal disc product.

By Gali Weinreb: Globes Online 01 FEB 2010


Polymer nanofabrics developer Nicast Ltd. Has obtained a three-year €4 million grant from EU Seventh Framework Progamme for Research and Development to head a consortium that will develop a spinal disc product. Nicast will head a group of ten companies and research institutes, and the company's share of the grant is €600,000.

 
Nicast produces electrospun nanofabrics, biomaterials made of ultra-thin polymer fibers, with properties that mimic those of human tissues and organs. The company's products include the AVflo vascular access graft for hemodialysis and the NovaMesh hernia mesh. The company obtained CE Mark certification for the AVflo in 2008, and plans to begin marketing of the NovaMesh in the Europe during the current quarter, pending regulatory approval.
 

  Directions     Privacy Policy     Site Map     Tel: +972.72.260.7000
©2010 The Trendlines Group Ltd. All rights reserved. This site contains material copyrighted by third parties.